Mirum Pharmaceuticals, Inc. MIRM Lease Payments
Lease Payments at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeasePayments.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s lease payments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s lease payments?
- Mirum Pharmaceuticals, Inc. (MIRM) reported lease payments of $810K in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s lease payments changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s lease payments increased by 38.9% year-over-year, from $583K to $810K.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s lease payments?
- Over 4 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s lease payments has grown at a 31.6% compound annual growth rate (CAGR), from $864K to $2.59M.
- What does lease payments mean?
- This represents the actual cash outflows made to satisfy lease obligations for facilities, equipment, or other assets. Unlike non-cash lease expenses, this reflects the tangible impact on the company's liquidity and cash position. It is essential for calculating the true cash burn rate of the business.